Mip-IN-1 (S,S-28i) is a novel inhibitor derived from rapamycin targeting the macrophage infectivity potentiator (Mip) proteins. It exhibits potent anti-enzymatic effects against Mip proteins from Neisseria meningitidis and Neisseria gonorrhoeae, significantly enhancing macrophage bactericidal efficacy [1].
Target:
Others|||Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted
